Engerix-b pedi 10 MCG/0.5 syrn 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP6ZX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,637
Award facts
- Contract value 100% obligated
- $3,637.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,637.44 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRINGE 0.5ML, a pediatric hepatitis B vaccine. This firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance to be executed from the contractor's facility in Park Ridge, Illinois. The award utilized no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a ceiling value of approximately $500 million and extends through November 2026. As a woman-owned small business pharmaceutical wholesaler, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities nationwide. The company has maintained a robust portfolio of federal contract awards with the Defense Logistics Agency since its registration with SAM.gov in 2001.
Quick answers
Who was awarded contract SPE2DB25FP6ZX?
SPE2DB25FP6ZX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FP6ZX worth?
The government has obligated $3,637 on SPE2DB25FP6ZX.
Is contract SPE2DB25FP6ZX an order under another contract?
Yes. SPE2DB25FP6ZX is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP6ZX competed?
The extent of competition for SPE2DB25FP6ZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award